
Telix Pharmaceuticals upsizes convertible bond offering to $600m
Telix Pharmaceuticals has upsized its convertible bond offering to $600m after strong institutional demand, pricing the five-year notes at a 1.5% coupon to fund a major repurchase of its existing 2029 paper.
1 day ago


